Can multidrug resistance mechanisms be modified?
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.02063.x/fullpdf
Reference57 articles.
1. Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar);Advani;Blood,1999
2. Reversal of multidrug resistance;Bates;Journal of Hematotherapy,1994
3. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833;Beketic-Oreskovic;Journal of the National Cancer Institute,1995
4. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes;Bertram;Anti-Cancer Drugs,1995
5. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells;Biscoff;Science,1996
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia;Cancer Biomarkers;2016-01-18
2. Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors;Cancer Chemotherapy and Pharmacology;2015-10-20
3. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells;European Journal of Pharmaceutics and Biopharmaceutics;2012-11
4. A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells;Drug Delivery and Translational Research;2012-01-07
5. Multidrug Resistance in Solid Tumor and Its Reversal;Pharmaceutical Perspectives of Cancer Therapeutics;2009
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3